Mergers & Acquisitions - Paladin Labs


Current filters:

Paladin Labs

Popular Filters

Valeant out-bids Paladin with C$76 million cash bid for Afexa


Acquisitive Canadian drugmaker Valeant Pharmaceuticals International (TSX: VRX) says that it has entered…

Afexa Life SciencesMergers & AcquisitionsPaladin LabsPharmaceuticalValeant Pharmaceuticals

Paladin Labs to buy troubled Labopharm in $20.6 million deal


Paladin Labs (TSX: PLB) has entered into a definitive agreement to acquire fellow Canadian drugmaker…

LabopharmMergers & AcquisitionsPaladin LabsPharmaceutical

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top